{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-020967","form_type":"8-K","ticker":"ICU","cik":"0001831868","company_name":"SeaStar Medical Holding Corp","filed_at":"2026-06-17T20:07:19+00:00","discovered_at":"2026-06-17T20:08:00.322941+00:00","generated_at":"2026-06-17T20:18:00.637204+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"SeaStar Medical shareholders approve equity plan increase to 896,546 shares; elect director","bullets":["Shareholders approved amendment to 2022 Omnibus Incentive Plan, increasing authorized shares from 207,046 to 896,546.","John Neuman elected as Class I director with 757,141 votes for, 23,212 against, and 4,829 abstentions (excluding broker non-votes).","WithumSmith+Brown, PC ratified as independent auditor for FY2026 with 2,151,096 votes for (98.5% of votes cast).","The increased share reserve provides additional capacity for future equity compensation to employees, directors, and consultants."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-020967","json":"https://secwatch.observer/filing/0001437749-26-020967.json","markdown":"https://secwatch.observer/filing/0001437749-26-020967.md","text":"https://secwatch.observer/filing/0001437749-26-020967.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831868/000143774926020967/0001437749-26-020967-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831868/000143774926020967/icu20260616_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T20:18:00.637204+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5bbec84ff6290f3af204f725ff782b5de120464b","claim":"SeaStar Medical Holding Corp shareholders approved Election of one Class I director to serve until the 2029 annual meeting of stockholders at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 1 . To elect one Class I director to serve until the 2029 annual meeting of stockholders, or until his successor shall have been duly elected and qualified: Nominee Votes For Votes Against Abstentions Broker Non-Votes John Neuman 757,141 23,212 4,829 1,395,732","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000143774926020967/0001437749-26-020967-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"director election"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"6df214cdc58de7145b598a27f8f141e3399865fb","claim":"SeaStar Medical Holding Corp shareholders approved Approve amendment and restatement of 2022 Omnibus Incentive Plan to increase authorized shares from 207,046 to 896,546 at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 2 . To approve an amendment and restatement of the Company’s 2022 Omnibus Incentive Plan to increase the number of authorized shares of Common Stock from 207,046, as adjusted for a January 5, 2026, 1-for-10 reverse stock split, to 896,546: Votes For Votes Against Abstentions Broker Non-Votes 551,233 223,813 10,136 1,395,732","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000143774926020967/0001437749-26-020967-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"equity plan"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"729f902997eecbf273fcafb38c88ff30d2f3331d","claim":"SeaStar Medical Holding Corp shareholders approved Approve adjournment or postponement of Annual Meeting to permit further solicitation if necessary at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 4 . To approve a proposal to adjourn or postpone the Annual Meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if there are insufficient votes for, or otherwise in connection with, any of the proposals described above: Votes For Votes Against Abstentions Broker Non-Votes 2,035,262 123,747 21,905 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000143774926020967/0001437749-26-020967-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"},{"claim_id":"a7799af229afaf808b8002ecd1aac2a73af34d44","claim":"SeaStar Medical Holding Corp shareholders approved Ratify appointment of WithumSmith+Brown, PC as independent registered public accounting firm for fiscal year ending December 31, 2026 at the 2026-06-17 meeting.","evidence_excerpt":"Proposal 3 . To ratify the appointment of WithumSmith+Brown, PC as our independent registered public accounting firm for the fiscal year ending December 31, 2026: Votes For Votes Against Abstentions Broker Non-Votes 2,151,096 22,746 7,072 —","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1831868/000143774926020967/0001437749-26-020967-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"auditor ratification"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2026-06-17"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}